Objective To investigate the causal relationship between gastroesophageal reflux disease (GERD) and bronchiectasis by using bidirectional two-sample Mendelian randomization (MR) analysis.
Methods Using a publicly available genome-wide association study aggregate data set. MR was performed using MR-Egger regression, weighted median estimator (WME), inverse variance weighting (IVW), simple mode(SM) and weighted mode(WM), which were used for MR Analysis of two samples to evaluate the causal relationship between GERD and bronchiectasis.
Results There was a causal relationship between GRED and an increased risk of bronchiectasis (OR=1.249, 95%CI: 1.023~1.523, P=0.028). The MR results did not find a causal effect of bronchiectasis on the risk of GERD (OR=1.015, 95%CI: 0.998~1.033, P=0.065). In the bidirectional MR analysis, there was no horizontal pleiotropy and heterogeneity among the instrumental variables. Sensitivity analysis using the leave-one method found that MR analysis results were robust.
Conclusion GERD is a risk factor for bronchiectasis, while there is no causal effect of bronchiectasis on the development of GERD.
1.中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 等. 胃食管反流病基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(7): 635-641. [Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of Gastroenterology, et al. Guideline for primary care of gastroesophageal reflux disease (2019)[J]. Chineese Journal of General Practttioners, 2019, 18(7): 635-641.] DOI: 10.3760/cma.j.issn.1671-7368. 2019.07.005.
2.Chan WW, Ahuja N, Fisichella PM, et al. Extraesophageal syndrome of gastroesophageal reflux: relationships with lung disease and transplantation outcome[J]. Ann N Y Acad Sci, 2020, 1482(1): 95-105. DOI: 10.1111/nyas.14460.
3.支气管扩张症专家共识撰写协作组, 中华医学会呼吸病学分会感染学组. 中国成人支气管扩张症诊断与治疗专家共识[J]. 中华结核和呼吸杂志, 2021, 44(4) : 311-321. [Bronchiectasis Expert Consensus Writing Group, Pulmonary Infection Assembly. Expert consensus on the diagnosis and treatment of adult bronchiectasis in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(4): 311-321.] DOI: 10.3760/cma.j.cn112147-20200617-00717.
4.Wang N, Qu JM, Xu JF. Bronchiectasis management in China, what we can learn from European Respiratory Society guidelines[J]. Chin Med J (Engl), 2018, 131(16): 1891-1893. DOI: 10.4103/0366-6999.238134.
5.Walker VM, Zheng J, Gaunt TR, et al. Phenotypic causal inference using genome-wide association study data: mendelian randomization and beyond[J]. Annu Rev Biomed Data Sci, 2022, 5: 1-17. DOI: 10.1146/annurev-biodatasci-122120-024910.
6.Ference BA, Holmes MV, Smith GD. Using Mendelian randomization to improve the design of randomized trials[J]. Cold Spring Harb Perspect Med, 2021, 11(7): a040980. DOI: 10.1101/cshperspect.a040980.
7.de Leeuw C, Savage J, Bucur IG, et al. Understanding the assumptions underlying Mendelian randomization[J]. Eur J Hum Genet, 2022, 30(6): 653-660. DOI: 10.1038/s41431-022-01038-5.
8.Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review[J]. Res Synth Methods, 2019, 10(4): 486-496. DOI: 10.1002/jrsm.1346.
9.Zullo A, Fiorini G, Bassotti G, et al. Upper endoscopy in patients with extra-oesophageal reflux symptoms: a multicentre study[J]. GE Port J Gastroenterol, 2020, 27(5): 312-317. DOI: 10.1159/000505581.
10.McDonnell MJ, Hunt EB, Ward C, et al. Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review[J]. ERJ Open Res, 2020, 6(4): 00190-2019. DOI: 10.1183/23120541.00190-2019.
11.Aksamit TR, O'Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry[J]. Chest, 2017, 151(5): 982-992. DOI: 10.1016/j.chest.2016.10.055.
12.McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study[J]. Lancet Respir Med, 2016, 4(12): 969-979. DOI: 10.1016/S2213-2600(16)30320-4.
13.Savarino V, Marabotto E, Zentilin P, et al. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease[J]. Expert Rev Clin Pharmacol, 2020, 13(4): 437-449. DOI: 10.1080/17512433.2020.1752664.
14.McDonnell MJ, O'Toole D, Ward C, et al. A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: current understanding and future risk[J]. Respir Med, 2018, 141: 132-143. DOI: 10.1016/j.rmed.2018.06.031.
15.Ahn B, Lee DH, Lee CM, et al. Effect of proton pump inhibitors in bronchiectatic patients with gastroesophageal reflux disease[J]. Korean J Gastroenterol, 2016, 68(1): 10-15. DOI: 10.4166/kjg.2016.68.1.10.
16.Hu ZW, Wang ZG, Zhang Y, et al. Gastroesophageal reflux in bronchiectasis and the effect of anti-reflux treatment[J]. BMC Pulm Med, 2013, 13: 34. DOI: 10.1186/1471-2466-13-34.
17.Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization[J]. Genet Epidemiol, 2016, 40(7): 597-608. DOI: 10.1002/gepi.21998.
18.Liu Y, Liu Z, Chen J, et al. Personal history of irradiation and risk of breast cancer: a Mendelian randomisation study[J]. J Glob Health, 2024, 14: 04106. DOI: 10.7189/jogh.14.04106.